Prenosis

Breaking News! Prenosis — an artificial intelligence company enabling precision medicine in acute care — is proud to announce that the FDA has granted marketing authorization (De Novo pathway) for the Sepsis ImmunoScore™, our AI diagnostic and predictive tool for early detection of sepsis. This signifies the first-ever FDA marketing authorization of an AI diagnostic tool for sepsis. Sepsis, a complex and deadly condition, claims more lives than all cancers combined. https://lnkd.in/g-crKfn6 Join us in celebrating this historic “first" for healthcare innovation! #Sepsis #AI #FDAApproval #Prenosis 

Prenosis’ Sepsis ImmunoScore™ received FDA De Novo authorization, marking the first-ever FDA marketing authorization of an #AI diagnostic tool for sepsis. This milestone was achieved thanks to the invaluable contributions from our dedicated partners at Mercy, one of the 25 largest U.S. health systems. Read Mercy's press release: https://lnkd.in/g9uf9PDD #AIinHealthcare #SepsisDiagnosis #FDAApproval #HealthcareInnovation #MedicalTechnology #Mercy #Prenosis

Thank you, The Nursing Beat.

It was a great privilege to take part in @3CT's workshop in Washington. Thank you, Alexandre Mebazaa, for a fantastic conference.

Prenosis’ Sepsis ImmunoScore™ received FDA De Novo authorization, the first-ever FDA marketing authorization of an #AI diagnostic tool for sepsis. This milestone was made possible thanks to the invaluable contributions from our dedicated partners at Mercy. Mercy's commitment to excellence in research and patient care has been instrumental in this achievement. FDA authorization is a testament to what we can achieve together. A special thank you to JoAnne Levy, J.D., M.B.A., Kelle Laws, Eric B., Phil Amelung, Greg Sonnenberg, Tiffany M., Amy Taylor, Kimberly Collison Farr, Preeti Srivastava, Clinton Ezekiel, Farid Sadaka, Saleem Azad, Nancy Kruse, Kate Hamilton, Tonya Moore, Susan Johnson, Michelle Cruse, Blair Buck, Amy Baumgartner, Sara McDaniel, Michelle Schaning, Miriam Engemann, Ashok Palagiri, Matthew Crisp, Karthik Iyer, Vikram Oke and the rest of the Mercy team. We look forward to continuing our partnership and making strides in medical innovation. #FDAApproval #Sepsis #AIDiagnostics #MedicalInnovation #HealthcareExcellence #Prenosis #MercyCollaborates

Headed to a very hot San Antonio for the #APIC24 conference. DM me if you'll be there. Let's chat about new innovations in #sepsis diagnosis, the cool things we are doing at Prenosis, and how we can partner over something very cold to drink!

Prenosis’ Sepsis ImmunoScore™ received FDA De Novo authorization, the first-ever FDA marketing authorization of an AI diagnostic tool for sepsis. The milestone would not have been possible without the invaluable contributions from our dedicated partners at Carle Health. Carle's commitment to excellence in research and patient care has been instrumental in this achievement. FDA authorization is a testament to what we can achieve together. Thank you James Kumar, MD; Benjamin Davis, MD; Karen White, MD, PhD; Jennifer Eardley, PhD; Lakita Scott, MSN, RN, CPHQ, NE-BC; Brad Weir, MD, FACEP, FAEMS, FAMPA and others at Carle.    We look forward to continuing our partnership and making strides in medical innovation. #Gratitude #SepsisImmunoScore #FDAApproval #MedicalResearch #HealthcareInnovation #AI #Prenosis #Carle

The Sepsis ImmunoScore™ "is better than anything else out there” -- Matthew Sims, MD PhD, Director of Infectious Diseases Research, Corewell Health East Thank you, Fox Corporation 2 Detroit, for shedding light on the critical impact of sepsis on patients and the groundbreaking potential of the Sepsis ImmunoScore™, the first FDA-authorized (De Novo) AI Diagnostic for sepsis. Prenosis' innovative approach to revolutionizing patient care through AI-driven sepsis detection was spotlighted in this article and TV news story: #HealthcareInnovation #AI #SepsisDetection #PatientCare #MedicalTechnology

"Leadership in Healthcare: Integrating AI for Optimal Outcomes" How do health providers successfully integrate #AI into workflows? Leaders must cultivate AI-savvy mindsets to navigate the transformation effectively. In healthcare, where we bear the weight of others' lives, incorporating AI into clinical workflows demands a nuanced approach. It's about understanding that effective human-AI collaboration transcends disciplinary boundaries. Diverse stakeholder involvement emerges as a cornerstone for AI success, as highlighted by the Harvard Business Review. Inclusivity within teams not only fosters innovation but also yields superior outcomes. To maximize #healthcare efficacy, both leaders and staff must recognize AI as a tool to enhance rather than replace clinical judgment. It's crucial to acknowledge that "AI cannot think like a human." However, when seamlessly integrated, AI can augment clinical decision-making processes. Transparency becomes paramount in facilitating genuine clinician-AI collaboration, ensuring that AI serves as a supportive ally in optimizing patient care. #NoBlackBoxes #HealthcareLeadership #AIIntegration #HealthTech #HealthcareInnovation #AIinHealthcare #ClinicalWorkflow #PatientCare #TransparencyInAI #HealthcareTech #AIinMedicine #HealthcareManagement #Prenosis

Thank you, National Science Foundation (NSF), for spotlighting the Sepsis ImmunoScore™, the first FDA-authorized (De Novo) #AI diagnostic for the rapid diagnosis and prediction of sepsis. Prenosis extends our deepest gratitude to the NSF for its recognition and support in advancing innovative solutions for healthcare challenges. Together, we're making strides toward a healthier, safer future. #MedicalInnovation #NSF #HealthcareAdvancement #Prenosis #FDAApproval #SepsisAwareness #HealthTech